Detalles de la búsqueda
1.
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial.
Int J Cancer
; 153(8): 1520-1528, 2023 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391938
2.
Intensity-modulated radiotherapy and cisplatin-based chemotherapy for anal cancer: long-term outcomes at a single institution.
Int J Colorectal Dis
; 38(1): 123, 2023 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37162567
3.
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
Oncologist
; 25(6): e928-e935, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943506
4.
Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.
Int J Colorectal Dis
; 35(4): 685-694, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32036405
5.
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Oncologist
; 24(3): 385-393, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30606884
6.
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC.
Future Oncol
; 14(14): 1339-1346, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846100
7.
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial.
Br J Cancer
; 117(8): 1099-1104, 2017 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28926529
8.
Severe contact urticaria, mimicking allergic contact dermatitis, due to a surgical mask worn during the COVID-19 pandemic.
Contact Dermatitis
; 84(6): 466-467, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33393078
9.
Cost effectiveness of different central venous approaches for port placement and use in adult oncology patients: evidence from a randomized three-arm trial.
Ann Surg Oncol
; 21(12): 3725-31, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24841352
10.
Brain metastases from colorectal cancer: main clinical factors conditioning outcome.
Int J Colorectal Dis
; 29(2): 201-8, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24158623
11.
Detection of circulating tumor cells in patients with locally advanced rectal cancer undergoing neoadjuvant therapy followed by curative surgery.
Int J Colorectal Dis
; 29(9): 1053-9, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25008360
12.
The role of anti-EGFR rechallenge in metastatic colorectal cancer, from available data to future developments: A systematic review.
Cancer Treat Rev
; 124: 102683, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38237253
13.
Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?
J Immunother Cancer
; 12(5)2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38782539
14.
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial.
JAMA Netw Open
; 7(4): e245635, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38592721
15.
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study.
J Clin Oncol
; 42(11): 1278-1287, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181312
16.
Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatment.
Ther Adv Med Oncol
; 16: 17588359241249602, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38882445
17.
Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: long-term results of a monocentric series of 137 radically resected patients in a 5-year period.
Int J Colorectal Dis
; 28(2): 207-15, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22903336
18.
Tumour-specific mesorectal excision for rectal cancer: Systematic review and meta-analysis of oncological and functional outcomes.
Eur J Surg Oncol
; 49(11): 107069, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37708660
19.
Observational Study on Antibody Response to COVID-19 Vaccines in PAtients with Gastro-Entero-PanCreatic Cancers and NeuroendocrIne NeoplAsms on Systemic TreatmEnts (VACCINATE).
Biomedicines
; 11(2)2023 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36830873
20.
Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer.
JAMA Netw Open
; 6(2): e230010, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36795409